methoctramine has been researched along with physostigmine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrisano, V; Banzi, R; Bartolini, M; Melchiorre, C; Minarini, A; Rosini, M; Tumiatti, V | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Aslan, AN; Oktay, S; Onat, F; Ozkutlu, U | 1 |
| Abdollahi, M; Dehpour, AR; Kebriaeezadeh, A; Mohammad, M; Samini, M; Sharifzadeh, M | 1 |
| Brefel-Courbon, C; Freslon, JL; Lazartigues, E; Montastruc, JL; Pelat, M; Rascol, O; Tellioglu, T; Tran, MA | 1 |
| Bernardi, G; Bonci, A; Grillner, P; Mercuri, NB; Svensson, TH | 1 |
| de Groat, WC; Ng, YK; Wu, HY | 1 |
| Arreola, JL; Chávez, J; Flores-Soto, E; Montaño, LM; Segura, P; Vargas, MH | 1 |
| Killi, UK; Kuca, K; Soukup, O; Tobin, G; Winder, M; Wsol, V | 1 |
| Karwoski, TE; Rhodes, ME; Rubin, RT; Smail, MA; Soles, JL | 1 |
| Andrisano, V; Bolognesi, ML; Budriesi, R; Cavalli, A; Cavrini, V; Melchiorre, C; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
| Andrisano, V; Angeli, P; Banzi, R; Bartolini, M; Cavalli, A; Marucci, G; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V | 1 |
13 other study(ies) available for methoctramine and physostigmine
| Article | Year |
|---|---|
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 3. Effect of replacing the inner polymethylene chain with cyclic moieties.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Piperidines; Polyamines; Structure-Activity Relationship | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Central muscarinic M2 cholinoceptors involved in cholinergic hypertension.
Topics: Animals; Blood Pressure; Diamines; Dose-Response Relationship, Drug; Female; Heart Rate; Injections, Intravenous; Injections, Intraventricular; Male; Muscarinic Antagonists; Oxotremorine; Physostigmine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic | 1993 |
Alterations of physostigmine-induced yawning by chronic lithium administration in rats.
Topics: Animals; Antimanic Agents; Atropine; Diamines; Dose-Response Relationship, Drug; Drug Synergism; Injections, Intraperitoneal; Injections, Intraventricular; Lithium Chloride; Male; Muscarinic Antagonists; Parasympatholytics; Physostigmine; Pirenzepine; Rats; Yawning | 1997 |
Pressor and bradycardic effects of tacrine and other acetylcholinesterase inhibitors in the rat.
Topics: Adrenergic Antagonists; Animals; Antidiuretic Hormone Receptor Antagonists; Atropine; Atropine Derivatives; Blood Pressure; Carbamates; Cardiovascular Agents; Chlorisondamine; Cholinergic Antagonists; Cholinesterase Inhibitors; Diamines; Diastole; Dose-Response Relationship, Drug; Heart Rate; Male; Phenylcarbamates; Physostigmine; Piperidines; Pirenzepine; Rats; Rats, Wistar; Rivastigmine; Systole; Tacrine | 1998 |
Presynaptic muscarinic (M3) receptors reduce excitatory transmission in dopamine neurons of the rat mesencephalon.
Topics: 4-Aminopyridine; Acetylcholine; Animals; Atropine; Carbachol; Diamines; Dicyclomine; Dopamine; Electric Stimulation; Excitatory Postsynaptic Potentials; Mesencephalon; Muscarine; Muscarinic Agonists; Muscarinic Antagonists; Neurons; Parasympatholytics; Physostigmine; Piperidines; Pirenzepine; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reaction Time; Receptor, Muscarinic M3; Receptors, Muscarinic; Synaptic Transmission; Tetrodotoxin | 1999 |
Muscarinic regulation of neonatal rat bladder spontaneous contractions.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Animals, Newborn; Calcium Channel Agonists; Carbachol; Cholinergic Agonists; Cholinesterase Inhibitors; Diamines; Electric Stimulation; Muscle Contraction; Muscle Hypertonia; Muscle, Smooth; Parasympatholytics; Peptides; Physostigmine; Piperidines; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Urinary Bladder | 2006 |
Paradoxical effect of salbutamol in a model of acute organophosphates intoxication in guinea pigs: role of substance P release.
Topics: Albuterol; Animals; Calcium; Cholinesterase Inhibitors; Colforsin; Diamines; Guinea Pigs; Lung; Male; Muscle Contraction; omega-Conotoxins; Parathion; Physostigmine; Pirenzepine; Plethysmography, Whole Body; Substance P; Tetrodotoxin; Tryptophan | 2007 |
In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the rat.
Topics: Animals; Atropine; Cholinesterase Inhibitors; Diamines; Dose-Response Relationship, Drug; Heart Atria; In Vitro Techniques; Male; Methacholine Chloride; Muscarinic Antagonists; Muscle Contraction; Obidoxime Chloride; Physostigmine; Rats; Receptor Cross-Talk; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Urinary Bladder | 2014 |
Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.
Topics: Adrenocorticotropic Hormone; Animals; Cholinesterase Inhibitors; Corticosterone; Diamines; Dose-Response Relationship, Drug; Female; Hypothalamo-Hypophyseal System; Male; Muscarinic Antagonists; Physostigmine; Pirenzepine; Pituitary-Adrenal System; Rats, Sprague-Dawley; Scopolamine; Sex Characteristics | 2018 |
Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibitors; Erythrocytes; Humans; Kinetics; Ligands; Models, Molecular; Polyamines; Receptor, Muscarinic M2; Receptors, Muscarinic; Structure-Activity Relationship | 1998 |
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 2. Role of the substituents on the phenyl ring and nitrogen atoms of caproctamine.
Topics: Acetylcholinesterase; Amides; Animals; Anisoles; Atrial Function; Butyrylcholinesterase; Cholinesterase Inhibitors; Diaphragm; Guinea Pigs; Heart Atria; Humans; In Vitro Techniques; Models, Molecular; Muscarinic Antagonists; Myocardial Contraction; Neuromuscular Blockade; Neuromuscular Junction; Polyamines; Rats; Receptor, Muscarinic M2; Receptors, Muscarinic; Stereoisomerism; Structure-Activity Relationship | 2003 |